Sign in

CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
383982704
Phone
6096193990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. UPLOAD Other SEC-generated Letter
  3. 8-K Event Other events
  4. EFFECT Other Notice of Effectiveness
  5. 424B3 Offering Prospectus
  6. D Other Notice of Sales of Unregistered Securities
  7. 4 Insider Changes in Ownership
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. S-3 Offering Registration Statement
  10. SC 13G Stake Amended Statement of Ownership
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. SC 13G Stake Amended Statement of Ownership
  13. UPLOAD Other SEC-generated Letter
  14. 8-K Event Executive or director change
  15. S-3 Offering Registration Statement
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. SC 13D/A Stake Beneficial Ownership Report
  20. 4 Insider Changes in Ownership

Page 10 of 42 · 833 filings